Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer

    1D-LSD Stats & Data

    Syn-l-229
    PubChem
    MW433.6
    FormulaC27H35N3O2
    LogP4.6
    IUPAC(6aR,9R)-4-(1,2-dimethylcyclobutanecarbonyl)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
    InChIKeyRNVFVHAKGPSAIU-ZRCBXKLVSA-N
    Chemical Class Lysergamide
    Psychoactive Class Psychedelic

    Receptor Profile

    Receptor Actions

    Agonists
    5-HT2A receptor agonist (partial)
    Other
    prodrug of LSD

    Effect Profile

    Curated
    Psychedelic 5.4

    Strong visuals with moderate body load, mild headspace

    Visual Intensity×3
    8
    Headspace Depth×3
    5
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    6
    Based on reports from:

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Cross-Tolerances

    LSD
    Psilocybin
    Psilocin
    Mescaline
    DMT
    5-MeO-DMT
    2C-B
    2C-E

    Experience Report Analysis

    Erowid
    4 Reports
    0 Single-substance
    2022–2025 Date Range
    4 With Age Data

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 4 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Not Specified 1 of 4
    • Male 3 of 4

    Age Distribution

    Reports Over Time

    Form / Preparation

    Most common forms and preparations, as a share of the 3 reports that give one

    Too few reports for bars: these forms come from 3 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Blotter / Tab 3 of 3

    Legal Status

    Country Status Notes
    Austria According to the current legal situation, 1D-LSD is neither explicitly mentioned in the Narcotic Drugs Ordinance nor in the Psychotropic Substances Ordinance (SV/PV), thus it is neither to be classified as a narcotic drug in the sense of the SV nor as a psychotropic substance in the sense of the PV.
    Germany Since the 14 June 2024 1D-LSD (and 1T-LSD) are covered by the German NpSG law.
    ← Back to 1D-LSD